nach oben

European Journal of Nutrition

Erschienen in:

01.12.2014 | Original Contribution

Maternal quercetin administration during gestation and lactation decrease endoplasmic reticulum stress and related inflammation in the adult offspring of obese female rats

verfasst von: Zhenghao Wu, Jiaxi Zhao, Hao Xu, Ying Lyv, Xin Feng, Yuehui Fang, Yajun Xu

Erschienen in: European Journal of Nutrition | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Maternal obesity is a risk factor for metabolic diseases in offspring. The aim of this study was to investigate whether quercetin administration during gestation and lactation could have any protective effect against the impact of maternal obesity on increased sensitivity to obesity and metabolic disorders in offspring.

Methods

Female Sprague–Dawley rats were fed a high-fat diet to induce obesity. Obese dams were administered 0, 50, 100 or 200 mg/kg body weight (BW) quercetin intragastrically during gestation and lactation. Normal weight dams were used as controls. The F1 generation was fed with a standard diet after weaning, and blood glucose, lipids and inflammatory factors were assessed. Expression of biomarkers involved endoplasmic reticulum (ER) stress, and related inflammatory pathways in liver and adipose tissues were analyzed at postnatal day 100.

Results

Maternal obesity resulted in increased birth weight, postnatal BW gain, hyperglycemia, hyperlipemia, hyperinsulinemia, increased serum levels of inflammatory factors, and up-regulated biomarkers involved in ER stress and related inflammatory pathways in the offspring. Maternal quercetin intervention (QI) had significant ameliorating effects on maternal blood lipids, especially cholesterol, which resulted in improved glucose metabolism and insulin sensitivity and alleviated ER stress and related inflammation in the grown offspring of obese dams.

Conclusions

Maternal QI in obese dams during gestation and lactation reduced birth weight and postnatal BW gain in the offspring, and helped to improve insulin sensitivity and lipid metabolism of the mature offspring via reducing ER stress and related inflammation in the liver and adipose tissue.

Hossain P, Kawar B, NahasM El (2007) Obesity and diabetes in the developing world–a growing challenge. N Engl J Med 356:213–215CrossRef

Parikh NI, Pencina MJ, Wang JT, Lanier KJ, Fox CS, D’Agostino RB, Vasan RS (2007) Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med 120:242–250CrossRef

WHO (2009) Obesity and overweight. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en

Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28CrossRef

Vahratian A (2009) Prevalence of overweight and obesity among women of childbearing age: results from the 2002 national survey of family growth. Matern Child Health J 13:268–273CrossRef

Ministry of Health of the People’s Republic of China (2002) The 2002 China health and nutrition survey

Reinhold T, von Schullzendorff A, Falk MR (2011) Economic consequences of overweight and obesity in Asia-Pacific. Eur J Integr Med 3:3–9CrossRef

Wu Y, Huxley R, Li M, MA J (2009) The growing burden of overweight and obesity in contemporary China. CVD Prev Control 4:19–26CrossRef

Barker DJP, Godfrey KM, Gluckman PD, Harding JE, Owens JA, Robinson JS (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341:938–941CrossRef

10.

Nathanielsz PW, Thornburg KL (2003) Fetal programming: from gene to functional systems- an overview. J Physiol 547:3–4CrossRef

11.

Barker DJP (2007) Obesity and early life. Obes Rev 8(suppl 1):45–49CrossRef

12.

Barker DJP (2007) The origins of the developmental origins theory. J Intern Med 261:412–417CrossRef

13.

Wein S, Behm N, Petersen RK, Kristiansen K, Wolffram S (2010) Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism. Eur J Pharm Sci 41:16–22CrossRef

14.

Ann J, Lee H, Kim S, Park J, Ha T (2008) The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373:545–549CrossRef

15.

Seiva Fabio RF, Chuffa LGA, Braga CP, Amorim JPA, Fernandes AAH (2012) Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatally monosodium glutamate-induced metabolic alterations. Food Chem Toxicol 50:3556–3561CrossRef

16.

Li JM, Wang C, Hu QH, Ling D (2008) Fructose induced leptin dysfunction and improvement by quercetin and rutin in rats. Chin J Nat Med 6:466–473CrossRef

17.

Liu C, Ma J, Sun Y (2010) Quercetin protects the rat kidney against oxidative stress-mediated DNA damaged and apoptosis induced by lead. Environ Toxicol Pharmacol 30:264–271CrossRef

18.

Borska S, Chmielewska M, Wysocka T, Drag-Zalesinska M, Zabel M, Dziegiel P (2012) In vitro effect of quercetin on human gastric carcinoma: targeting cancer cells death and MDR. Food Chem Toxicol 50:3375–3383CrossRef

19.

Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T (2011) Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 218:44–52CrossRef

20.

Morikawa K, Nonakaa M, Naraharaa M, Torii I, Kawaguchi K, Yoshikawa T, Kumazawa Y, Morikawa S (2003) Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci 74:709–721CrossRef

21.

Anhe FG, Okamoto MM, Kinote A, Sollo C, LellisSantos C, Anhe FF, Lima GA, Hirabara SM, Velloso LA, Bordin S, Machado UF (2012) Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. Eur J Pharmacol 689:285–293CrossRef

22.

Ambrose JM, Robbins DJ, DeEds F (1952) Comparative toxicities of quercetin and quercitrin. J Am Pharm Assoc 41:119–122CrossRef

23.

Willhite CC (1982) Teratogenic potential of quercetin in the rat. Food Chem Toxicol 20:75–79CrossRef

24.

Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900–917CrossRef

25.

Ozcan U, Cao Q, Yilmaz E (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457–461CrossRef

26.

Chevet E, Cameron PH, Pelletier MF, Thomas D, Bergeron JJM (2011) The endoplasmic reticulum :integration of protein folding, quality control, signaling and degradation. Curr Opin Struct Biol 11:120–124CrossRef

27.

Bertolotti A, Zhang Y (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2:326–332CrossRef

28.

Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, Sonenberg N, Harding HP, Ron D (2004) Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol 24:10161–10168CrossRef

29.

Hu P, Han Z, Couvillon AD, Kaufman R, Exton JH (2006) Autocrinetumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-κB activation and down-regulation of TRAF2 expression. Mol Cell Biol 26:3071–3084CrossRef

30.

Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287:664–666CrossRef

31.

Tai MM (1994) A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152–154CrossRef

32.

Poston L (2012) Maternal obesity, gestational weight gain and diet as determinants of offspring long term health. Best Pract Res ClinEndocrinolMetab 26:627–639CrossRef

33.

Bayol SA, Simbi BH, Bertrand JA, Stickland NC (2008) Offspring from mothers fed a ‘junk food’ diet in pregnancy and lactation exhibit exacerbated adiposity that is more pronounced in females. J Physiol 586:3219–3230CrossRef

34.

Sullivan EL, Smith MS, Grove KL (2011) Perinatal exposure to high-fat diet programs energy balance, metabolism and behavior in adulthood. Neuroendocrinology 93:1–8CrossRef

35.

Mello MA, Souza CT, Braga LR, Santos JW, Ribeiro IA, Gobatto CA (2001) Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol Chem Phys Med NMR 33:63–71

36.

Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y (1998) Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859–862

37.

Robert E, Francannet C, Shaw G (1995) Neural tube defects and maternal weight reduction in early pregnancy. Repro Toxicol 9:57–59CrossRef

38.

Skibola CF, Smith MT (2000) Pothential health impacts of excessive flavonoid intake. Free RadicBiol Med 29:375–383CrossRef

39.

Manach C, Williamson G, Morand C, Scalbert A, Rernesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242S

40.

Prater MR, Laudermilch CL, Liang C, Holladay SD (2008) Placental oxidative stress alters expression of murine osteogenic genes and impairs fetal skeletal formation. Placenta 29:802–808CrossRef

41.

Egert S, Bosy-Westphal A, Seiberl J, Kürbitz C, Settler U, Plachta-Danielzik S, Wagner AE, Frank J, Schrezenmeir J, Rimbach G, Wolffram S, Müller MJ (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102:1065–1074CrossRef

42.

Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi Christine, Wagner Anika Eva, Frank Jan, Rimbach Gerald, Mueller Manfred James (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nur 138:1615–1621

43.

Egert S, Rimbach G, Müller MJ (2011) No evidence for a thermic effect of the dietary flavonol quercetin: a pilot study in healthy normal-weight women. Eur J Appl Physiol 111:869–873CrossRef

44.

Boesch-Saadatmandi Wagner AE, Wolffram S, Rimbach G (2012) Effect of quercetin on inflammatory gene expression in mice liver in vivo—role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol Res 65:523–530CrossRef

45.

Am Lee (2005) The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 35:373–381CrossRef

46.

Chen LW, Egan L, Li Z, Greten FR, Kagnoff MF, Karin M (2003) The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 9:575–581CrossRef

47.

Arkan MC, Hevener AL, Greten FR, Maeda S, Li Z, Long JM, Anthony WB, Poli G, Olefsky J, Karin M (2005) IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11:191–198CrossRef

48.

Panchal Sunil K, Poudyal Hemant, Brown Lindsay (2012) Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr 142:1026–1032CrossRef

49.

50.

Vsllrtir SN, Furuhashi M, Fucho R, Hotamisligil GS (2008) A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS ONE 3:e3151CrossRef

51.

Boesch-Saadatmandi Loboda A, Wagner AE, Stachurska A, Jozkowicz A, Dulak J, Döring F, Wolffram S, Rimbach G (2011) Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem 22:293–299CrossRef

Titel: Maternal quercetin administration during gestation and lactation decrease endoplasmic reticulum stress and related inflammation in the adult offspring of obese female rats
verfasst von: Zhenghao Wu
Jiaxi Zhao
Hao Xu
Ying Lyv
Xin Feng
Yuehui Fang
Yajun Xu
Publikationsdatum: 01.12.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 8/2014
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-014-0673-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Maternal quercetin administration during gestation and lactation decrease endoplasmic reticulum stress and related inflammation in the adult offspring of obese female rats

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2014

Inhibition of angiotensin-converting enzyme by aqueous extract of tomato

Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice

Effect of chicken, fat and vegetable on glycaemia and insulinaemia to a white rice-based meal in healthy adults

Effects of regular consumption of vitamin C-rich or polyphenol-rich apple juice on cardiometabolic markers in healthy adults: a randomized crossover trial

Dose–response effects of oral guanidinoacetic acid on serum creatine, homocysteine and B vitamins levels

Influence of oral supplementation with sesamin on longevity of Caenorhabditis elegans and the host defense

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin